| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jennifer Linn | Q37829951 |
| Andreas Charidimou | Q47157886 | ||
| Jean-Claude Baron | Q56877270 | ||
| Christian Opherk | Q71921777 | ||
| P2093 | author name string | Steven M Greenberg | |
| Andreas Charidimou | |||
| David J Werring | |||
| Meike W Vernooij | |||
| Hans Rolf Jäger | |||
| Saloua Akoudad | |||
| P433 | issue | Pt 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebral amyloid angiopathy | Q191562 |
| P304 | page(s) | 2126-2139 | |
| P577 | publication date | 2015-06-26 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions | |
| P478 | volume | 138 |
| Q36117715 | A murine model of inflammation-induced cerebral microbleeds |
| Q64069480 | Advances in cerebral amyloid angiopathy imaging |
| Q33700069 | Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update |
| Q40422620 | Aneurysmal wall imaging in a case of cortical superficial siderosis and multiple unruptured aneurysms |
| Q92188340 | Application of an Imaging-Based Sum Score for Cerebral Amyloid Angiopathy to the General Population: Risk of Major Neurological Diseases and Mortality |
| Q38813005 | Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage |
| Q93133881 | Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies |
| Q38659385 | Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis |
| Q59813512 | Cerebral Microbleeds in the Patients With Acute Stroke Symptoms |
| Q31108748 | Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment |
| Q55369085 | Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q26771852 | Cerebrovascular disease in ageing and Alzheimer's disease |
| Q47913191 | Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy |
| Q95550810 | Cognitive status after intracerebral haemorrhage |
| Q37730994 | Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy |
| Q89531322 | Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage: A prognostic marker |
| Q92352842 | Cortical Superficial Siderosis Evolution |
| Q48229518 | Cortical Superficial Siderosis Presumed due to Cerebral Amyloid Angiopathy: Minimum Standards for Rating and Reporting |
| Q47752887 | Cortical superficial siderosis and acute convexity subarachnoid hemorrhage in cerebral amyloid angiopathy |
| Q38737900 | Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy |
| Q47603370 | Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: A prospective study |
| Q42737128 | Cortical superficial siderosis predicts early recurrent lobar hemorrhage |
| Q40618153 | Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population |
| Q64085110 | Decreased CSF Levels of ß-Amyloid in Patients With Cortical Superficial Siderosis |
| Q90358532 | Delayed Identification of Cortical Superficial Siderosis in a Patient with Recurrent Transient Focal Neurological Symptoms: A Case Report |
| Q48677392 | Dementia after stroke due to intracerebral haemorrhage |
| Q38873328 | Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study |
| Q50043256 | Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria |
| Q47117098 | Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy. |
| Q97419421 | Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage |
| Q91670427 | Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis |
| Q64122132 | Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA |
| Q92294160 | Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial |
| Q39196370 | Emerging concepts in sporadic cerebral amyloid angiopathy |
| Q48000789 | Evolution of DWI lesions in cerebral amyloid angiopathy: Evidence for ischemia. |
| Q92761056 | Fluid-Blood Level and Hematoma Expansion in a Cerebral Amyloid Angiopathy-Associated Intracerebral Hematoma |
| Q88585389 | Focal cortical superficial siderosis due to hemorrhagic transformation of cortical microinfarction |
| Q55249019 | Focused Neuro-Otological Review of Superficial Siderosis of the Central Nervous System. |
| Q90120976 | Incidence and determinants of cerebrovascular events in outpatients with stable coronary artery disease |
| Q40431162 | Infratentorial superficial siderosis: Classification, diagnostic criteria, and rational investigation pathway. |
| Q52902903 | MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. |
| Q49790347 | Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk |
| Q64991552 | Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives. |
| Q47368980 | Patterns of convexal subarachnoid haemorrhage: clinical, radiological and outcome differences between cerebral amyloid angiopathy and other causes. |
| Q47602999 | Prevalence and Natural History of Superficial Siderosis: A Population-Based Study |
| Q48004067 | Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke |
| Q92257524 | Recent Advances in the Treatment of Cerebellar Disorders |
| Q33825171 | Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis |
| Q40361221 | Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage |
| Q48171450 | Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke. |
| Q90008084 | Superficial siderosis misdiagnosed as idiopathic bilateral neurosensorial deafness |
| Q57157880 | The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation |
| Q38695408 | The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts |
| Q38636940 | The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. |
| Q42373712 | Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort |
| Q39639734 | Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation |
Search more.